Hamilton Lane Incorporated reports developments tied to its private markets investment platform, which provides investment solutions for institutional and private wealth clients. Company news commonly covers earnings releases, private credit and private infrastructure products, interval fund structures, capital-structure actions, and funds managed by Hamilton Lane participating in private equity, renewable infrastructure, and continuation-vehicle transactions.
Updates also include senior promotions across investment and client functions and product-access initiatives such as daily NAV pricing, quarterly repurchase features, and tokenized access where offered through specific fund structures.
Hamilton Lane (Nasdaq: HLNE) expanded its infrastructure team with three senior appointments across North America and Europe to support platform growth. Tara Speers joins as Managing Director on the Product team in Toronto, responsible for infrastructure capital formation. Lucas May joins as Principal in Conshohocken, and Colin Mooney joins as Vice President in London, both in infrastructure investing.
As of June 30, 2026, the platform represented approximately $111.7 billion in assets under management and supervision. In the first half of calendar 2026, it sourced or evaluated $49.4 billion in transactions and deployed more than $1.2 billion across discretionary transactions. Its two evergreen infrastructure funds surpassed a combined $1.26 billion in assets under management as of June 30, 2026.
Cosette Pharmaceuticals is maintaining full availability of RYANODEX injectable suspension for healthcare providers in the United States and international markets.
Cosette acquired RYANODEX (dantrolene sodium) from Eagle Pharmaceuticals in June 2026 and completed the supply chain transition. The company is using its established manufacturing and distribution capabilities to maintain supply.
Hamilton Lane (HLNE) reported results for its second fiscal quarter ended September 30, 2026, and declared a quarterly dividend. The detailed fiscal 2027 second-quarter results presentation is available on the company's Shareholders website.
The $0.60 per share Class A common stock dividend will be paid on January 7, 2027, to holders of record at the close of business on December 21, 2026. The company targets a $2.40 full-year dividend, representing an 11% increase from the prior fiscal year dividend.
FactSet (FDS) and Hamilton Lane (HLNE) announced a partnership to integrate private markets data into FactSet's portfolio analytics platform.
Hamilton Lane's data covers more than 70,000 funds and 240,000 assets as of June 30, 2026. The planned integration is designed to provide private markets benchmarks, support risk and investment commitment pacing models, and bring public and private portfolio monitoring into one workflow. Clients would be able to create custom benchmarks within FactSet's performance measurement tools. Further details on product availability and expanded capabilities will be shared in the coming months.
Cosette Pharmaceuticals received FDA approval for EVOXAC oral solution to treat symptoms of dry mouth in adults with Sjögren’s disease. This is Cosette’s first New Drug Application approval. The internally developed formulation contains cevimeline hydrochloride, the same active ingredient as EVOXAC capsules, and offers an alternative for patients who may have difficulty swallowing capsules.
The approval pathway relied partly on existing safety and efficacy data for Cosette’s previously approved capsules, without a full-scale clinical development program. Cosette expects U.S. commercial availability by the end of 2026. The medicine carries warnings for heart rhythm and heart rate problems, lung problems, vision changes and nervous system reactions. Cosette is backed by Avista Healthcare Partners and funds managed by Hamilton Lane (Nasdaq: HLNE).
Hamilton Lane (HLNE) named Hartley Rogers Co-Chief Executive Officer alongside Juan Delgado-Moreira, while Erik Hirsch became Executive Co-Chairman. Rogers will remain Chairman of the Board, and Delgado-Moreira has served as Co-Chief Executive Officer since January 1, 2024.
In his new role, Hirsch will help lead initiatives intended to advance the firm's long-term growth. He remains a board member and will continue speaking on behalf of Hamilton Lane in the media and on earnings calls. Hirsch identified investing capital, creating partnerships and acquisitions as areas of focus amid technological changes and an expanding client base.
Hamilton Lane (HLNE) is scheduled to release second-quarter fiscal 2027 results before the market opens on November 3, 2026. The quarter ended September 30, 2026. The earnings release and detailed presentation will be available on its shareholder website.
A webcast to discuss the results will begin at 11:00 a.m. ET that day. A replay will be available approximately two hours after the live broadcast and remain accessible for one year.
Hamilton Lane (HLNE) announced Executive Co-Chairman Mario Giannini will retire effective March 31, 2027, after more than three decades at the firm.
Giannini joined in 1993 and served as CEO from 2001 through 2023, when he became Executive Co-Chairman. Juan Delgado-Moreira and Erik Hirsch succeeded him as co-CEOs. Giannini will author Hamilton Lane's 2027 Market Overview before retiring. After his retirement, Hartley Rogers, currently the other Executive Co-Chairman, will continue as Executive Chairman and Chairman of the Board.
Hamilton Lane (HLNE) funds managed by the firm have completed a $105 million structured investment in Ontario fibre internet provider telMAX, alongside a parallel $110 million upsize of telMAX's existing credit facility from Power Sustainable Infrastructure Credit, Palistar Capital and MidStar Capital.
The combined $215 million growth financing is described as one of the largest rounds secured by an independent Canadian digital infrastructure business and is expected to accelerate telMAX's expansion of its 100% fibre network across Ontario. telMAX has already extended service to Markham, Barrie and Oakville and continues building across the Greater Toronto Area, including Brooklin, Stouffville, Newmarket, Aurora and Richmond Hill. With the new capital, telMAX plans to enter Burlington, Brampton and Mississauga, bringing high-speed fibre connectivity to hundreds of thousands of additional homes and businesses.
Columbia Threadneedle Investments (AMP) and Hamilton Lane (HLNE) announced a strategic collaboration to deliver investment solutions to the wealth channel, combining Columbia Threadneedle’s public markets and multi-asset capabilities with Hamilton Lane’s private markets platform and data analytics.
As part of this collaboration, Columbia Threadneedle filed a preliminary registration statement with the U.S. Securities and Exchange Commission for the Columbia Hamilton Lane Growth Innovation Fund/b, a public-private growth equity interval fund to be managed by Columbia Threadneedle. The fund’s launch is subject to SEC registration effectiveness and fund board approval and is expected to be offered to the wealth channel through financial advisors. Columbia Threadneedle reports it manages and advises of assets as of June 30, 2026, while Hamilton Lane reports $1.1 trillion in assets under management and supervision, including more than $146 billion in discretionary assets.